| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.1 |